Literature DB >> 32857457

All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis.

Amy Peacock1,2, Lucy Thi Tran1, Sarah Larney1,3, Emily Stockings1, Thomas Santo1, Hayley Jones4, Damian Santomauro5,6, Louisa Degenhardt1.   

Abstract

AIMS: To estimate pooled all-cause and cause-specific mortality risk for people with regular or problematic cocaine use.
METHODS: Systematic review and meta-analysis of prospective or retrospective cohort studies or clinical trials (n ≥30) of people with regular or problematic cocaine use with data on all-cause or cause-specific mortality. Of 2808 papers, 28 were eligible and reported on 21 cohorts, with a total 170 019 individuals. Cohorts identified based on acute care for drug poisoning or other severe health presentation were excluded. Title/abstract screening was conducted by one reviewer; a second reviewer independently checked 10% of excluded studies. Two reviewers conducted full-text screening. Data were extracted by one reviewer and checked by a second. A customized review-specific study reporting quality/risk of bias tool was used. Data on crude mortality rates (CMR) and standardized mortality ratios were extracted for both all-cause and cause-specific mortality. Standardized mortality ratios were imputed where not provided by the author using extracted data and information from the Global Burden of Disease Study 2017. Data were pooled using a random-effects model.
RESULTS: The pooled all-cause crude mortality rate was 1.24 per 100 person-years [95% confidence interval (CI) = 0.86, 1.78; n = 16 cohorts], but with considerable heterogeneity (I2  = 98.8%). The pooled all-cause standardized mortality ratio (SMR) was 6.13 (95% CI = 4.15, 9.05; n = 16 cohorts). Suicide (SMR = 6.26, 95% CI = 2.84, 13.80), accidental injury (SMR = 6.36, 95% CI = 4.18, 9.68), homicide (SMR = 9.38, 95% CI 3.45-25.48) and AIDS-related mortality (SMR = 23.12, 95% CI = 11.30, 47.31) were all elevated compared with age and sex peers in the general population.
CONCLUSIONS: There are elevated rates of mortality among people with regular or problematic cocaine use for traumatic deaths and deaths attributable to infectious disease.
© 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Cardiovascular; cocaine; homicide; infectious disease; injury; mortality; suicide

Mesh:

Substances:

Year:  2020        PMID: 32857457      PMCID: PMC7914269          DOI: 10.1111/add.15239

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  51 in total

Review 1.  A systematic review of psychosocial suicide prevention interventions for youth.

Authors:  Alison L Calear; Helen Christensen; Alexander Freeman; Katherine Fenton; Janie Busby Grant; Bregje van Spijker; Tara Donker
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-10-15       Impact factor: 4.785

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

3.  Alcohol- or drug-use disorders and motor vehicle accident mortality: a retrospective cohort study.

Authors:  Russell C Callaghan; Jodi M Gatley; Scott Veldhuizen; Shaul Lev-Ran; Robert Mann; Mark Asbridge
Journal:  Accid Anal Prev       Date:  2013-02-01

4.  Mortality in a cohort of young primary cocaine users: controlling the effect of the riskiest drug-use behaviors.

Authors:  Gregorio Barrio; Gemma Molist; Luis de la Fuente; Fermín Fernández; Anna Guitart; María J Bravo; M Teresa Brugal
Journal:  Addict Behav       Date:  2012-10-22       Impact factor: 3.913

5.  Impact of HIV infection on mortality in a cohort of injection drug users.

Authors:  M W Tyndall; K J Craib; S Currie; K Li; M V O'Shaughnessy; M T Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-01       Impact factor: 3.731

Review 6.  Disulfiram for the treatment of cocaine dependence.

Authors:  Pier Paolo Pani; Emanuela Trogu; Rosangela Vacca; Laura Amato; Simona Vecchi; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  Psychostimulant drugs for cocaine dependence.

Authors:  Xavier Castells; Ruth Cunill; Clara Pérez-Mañá; Xavier Vidal; Dolors Capellà
Journal:  Cochrane Database Syst Rev       Date:  2016-09-27

Review 8.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

9.  Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial.

Authors:  Bridget A Martell; Frank M Orson; James Poling; Ellen Mitchell; Roger D Rossen; Tracie Gardner; Thomas R Kosten
Journal:  Arch Gen Psychiatry       Date:  2009-10

10.  The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.

Authors:  Lisa Bero; Nicholas Chartres; Joanna Diong; Alice Fabbri; Davina Ghersi; Juleen Lam; Agnes Lau; Sally McDonald; Barbara Mintzes; Patrice Sutton; Jessica Louise Turton; Tracey J Woodruff
Journal:  Syst Rev       Date:  2018-12-21
View more
  1 in total

1.  All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000-15: a retrospective study.

Authors:  Ana Paula Souto Melo; Ilse N Dippenaar; Sarah Charlotte Johnson; Nicole Davis Weaver; Francisco de Assis Acurcio; Deborah Carvalho Malta; Antônio Luiz P Ribeiro; Augusto Afonso Guerra Júnior; Eve E Wool; Mohsen Naghavi; Mariangela Leal Cherchiglia
Journal:  Lancet Psychiatry       Date:  2022-08-11       Impact factor: 77.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.